The recent release of the report of the Institute of Medicine's Committee on Developing Evidence-Based Standards for Psychosocial Interventions for Mental Disorders titled, "Psychosocial Interventions for Mental and Substance Use Disorders: A Framework for Establishing Evidence-Based Standards," (England, Butler & Gonzalez, 2015) serves as yet another stark reminder that the mental health needs of persons in the United States are not being adequately and reliably addressed. Unlike treatments for many other chronic diseases that are standardized through development and implementation of empirically supported clinical guidelines, nonpharmacological psychosocial interventions have failed to congeal into standardized protocols that are routinely and reliably delivered.
In their report, the Committee proposed several key activities that must be accomplished in order to bring evidenced-based psychosocial interventions into clinical care. Among them is the call for research to refine and test existing models of psychosocial interventions and to develop and test new interventions to address the unmet needs of this large and underserved segment of our population.
In Healthy People 2020, health disparity is defined as "a particular type of health difference that is closely linked with social, economic, and/or environmental disadvantage" (U.S. Department of Health and Human Services, 2011). Without question, persons with mental illness experience high and unequal burden of untreated and inadequately treated physical illness and a significantly shortened life expectancy of 8 to 17 years (Chang et al., 2011) . Early death has been related to lifestyle habits (smoking, diet, exercise) and chronic diseases that are diagnosed late in life and poorly treated. Improved diagnosis of mental disorders such as schizophrenia, severe autism, and bipolar disorder has led to earlier recognition and treatment, which lengthens the window of opportunity for health promotion and prevention of the comorbidities that lead to premature death.
Despite earlier diagnosis of mental disorders, a remarkably low proportion of studies funded by the National Institutes of Health (NIH) address the multiple and diverse health needs of persons with mental illness. We propose two possibilities for the lack of studies. First, persons with mental disorders are distinguished from other populations suffering from chronic illness such as diabetes, in which different dimensions of the disorder and the health care needs of the population are addressed across multiple institutes. A quick review of NIH-funded projects using e-Reporter shows that research focused on diabetes is funded by multiple institutes including the National Institute of Diabetes & Digestive & Kidney Diseases, the National Institute of Nursing Research, the National Institute of Mental Health, and the National Center for Complementary and Integrative Health, with each institute contributing from their unique perspective to the prevention, treatment, and management of the disorder. The number of institutes addressing health issues in persons with mental disorders is more limited. Second, and perhaps most important, the issue of integrated health care that is sensitive and responsive to the unique characteristics of the specific population is a national priority. Certainly there is broad recognition that the delivery of health care must take into account characteristics such as race and ethnicity, gender, and sexual minority status as a personal context within which health care delivery must be adapted to be acceptable and effective. Yet even in this era in which it is a national health care priority to recognize and respect diversity, persons with mental illness are not included. The health needs of persons with mental disorders, whether issues of weight control, smoking cessation, disturbed sleep, management of chronic illnesses, or end-of-life issues, are not considered a part of the shared human condition. Rather, persons with mental disorders are considered by the NIH to be a distinct and separate group defined solely by their mental disorder.
As most investigators dedicated to research on the health needs of persons with mental disorders know, federal funds to support nonbiological approaches to intervention are limited and access to funding is complicated by the NIH institute structure. Not surprisingly, persons with mental disorders such as depression, schizophrenia, anxiety disorders, and posttraumatic stress disorder have multiple and complex health needs that extend beyond the boundaries of their mental disease. For example, approximately 8.4 million people with a mental disorder concurrently struggle with alcohol and other drug addictions (http://www.samhsa.gov/disorders); in addition, persons with mental disorders have high rates of chronic physical illnesses including type 2 diabetes and hypertension that require ongoing self-care activities that are complicated by emotional, cognitive, and social limitations. Similarly, persons with mental disorders, like all other populations, suffer from cancers, heart disease, and other terminal illness that require palliative and end-of-life care that also must be tailored to the special needs of this population. Psychosocial interventions to address these human health issues are essential to meet the goal of reducing symptoms of the mental disorders and improving overall functional health and well-being. Yet it is these very health needs that fall through the cracks in the NIH system with its institute organization defined by disease entities and their nonoverlapping strategic plans and missions.
The research priorities of our own institute, the National Institute of Nursing Research (NINR), including symptom science, wellness, self-management, end-of-life and palliative care, and technology, are central to health and wellbeing of all populations. Furthermore, cutting-edge research in these topical areas is central to the delivery of the highest-quality evidence-based nursing care. Yet it appears that as soon as a named mental disorder becomes part of a proposal to the NINR, it is deferred to the National Institute of Mental Health (NIMH) even when the scientific intent falls squarely within NINR research priorities. While NIMH modestly supports research that addresses psychosocial interventions to improve health in the mentally ill, the priority for NIMH is the neurological and genetic foundations of mental illness. NINR, the ideal institute for such proposals, generally has not welcomed applications that test psychosocial health interventions in populations with mental disorders. This chasm between institutes has left providers without empirically tested psychosocial interventions to promote health, prevent or reduce symptoms of comorbid conditions, and improve health quality of life that are tailored specifically for people with mental illness. Furthermore, exclusion of one population, whether based on race/ethnicity, sexual orientation, or mental status, is a bias, which in this case contributes to continued stigmatization of a large and extremely vulnerable segment of the population.
Interventions to prevent disease or manage symptoms of health conditions that are effective for individuals without mental disorders cannot be transferred directly to people with mental illness. Mental illness creates profound alterations in communication, information processing, behavioral regulation, and mood that require interventions that compensate for these alterations. For example, without compensatory elements, a reminder system for diabetes care that works for individuals without schizophrenia will not compensate for the profoundly disrupted information processing and motivation accompanying this disorder. In a proposal, the rationale for including intervention components that address these specific alterations make sense only in the context of symptom management with people diagnosed with schizophrenia. Thus, the argument for testing such an intervention must include specific references to the mental disorder and must be tested in people with schizophrenia. To place "schizophrenia" in the title will route a proposal away from NINR and place it into NIMH, whose priorities do not include symptom management in chronic disease.
The consequences appear in the underfunded areas of health promotion, symptom management, and end-of-life care in people with serious mental illness and a continuing lack of controlled tests of effective interventions. Without carefully controlled studies testing interventions that compensate for the unique phenomena associated with distinct mental disorders, people with these diagnoses will continue to have reduced quality of health, shortened lives, and poor-quality end-of life care. Psychiatric nurses can step forward and articulate concerns about the lack of interest and resources that are currently being directed toward the health and well-being of people with serious mental illnesses. The American Psychiatric Nurses Association can take a step forward by convening its member-experts to assess the current status of psychiatric mental health nursing science directed toward psychosocial interventions to promote health, prevent comorbid conditions, manage the symptoms of comorbid health conditions effectively, and improve palliative and end-oflife care. This congress of member-experts could be charged with the mission of creating a policy statement directed to Congress and the NIH to resolve the barriers preventing adequate funding for such proposals. Strong allies such as NAMI (National Alliance on Mental Illness) will partner around this initiative and provide compelling accounts of the consequences of excluding individuals with serious mental illness from mainstream health care innovations. Together, the American Psychiatric Nurses Association and consumers can assure that all people with mental disorders have an equal opportunity for health, well-being, a full lifespan, and a dignified death.
